These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7121387)

  • 61. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin.
    Beauchamp D; Laurent G; Grenier L; Gourde P; Zanen J; Heuson-Stiennon JA; Bergeron MG
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1237-45. PubMed ID: 9174177
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative nephrotoxicity and tissue accumulation of dactimicin, amikacin and gentamicin.
    Bonadio M; Maccanti O; Giovannini L; Bertelli AA; Scalori V; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):747-50. PubMed ID: 3447878
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides.
    Meyer RD
    Am J Med; 1986 Jun; 80(6B):119-25. PubMed ID: 3524214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mentha piperita in nephrotoxicity--a possible intervention to ameliorate renal derangements associated with gentamicin.
    Ullah N; Khan MA; Khan T; Asif AH; Ahmad W
    Indian J Pharmacol; 2014; 46(2):166-70. PubMed ID: 24741187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections.
    Walker BD; Gentry LO
    J Infect Dis; 1976 Aug; 134 Suppl():S146-9. PubMed ID: 787449
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Temporal modulation of nephrotoxicity, feeding, and drinking in gentamicin-treated rats.
    Julien N; Karzazi M; Labrecque G; Beauchamp D; Thibault L
    Physiol Behav; 2000 Feb; 68(4):533-41. PubMed ID: 10713294
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
    Viotte G; Olier B; Morin JP; Godin M
    Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative ototoxicity of netilmicin, gentamicin, and tobramycin in cats.
    McCormick GC; Weinberg E; Szot RJ; Schwartz E
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):479-89. PubMed ID: 3975915
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recovery from aminoglycoside nephrotoxicity with continued drug administration.
    Luft FC; Rankin LI; Sloan RS; Yum MN
    Antimicrob Agents Chemother; 1978 Sep; 14(3):284-7. PubMed ID: 708007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides.
    Raveh D; Kopyt M; Hite Y; Rudensky B; Sonnenblick M; Yinnon AM
    QJM; 2002 May; 95(5):291-7. PubMed ID: 11978900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats.
    Shifow AA; Kumar KV; Naidu MU; Ratnakar KS
    Nephron; 2000 Jun; 85(2):167-74. PubMed ID: 10867523
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Update on drug therapy: IX. Gentamicin and tobramycin nephrotoxicity.
    Darr MS; Elenbaas JK
    J Am Med Womens Assoc (1972); 1981 Oct; 36(10):310-6. PubMed ID: 7346536
    [No Abstract]   [Full Text] [Related]  

  • 74. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients.
    Reed RL; Wu AH; Miller-Crotchett P; Crotchett J; Fischer RP
    J Trauma; 1989 Nov; 29(11):1462-8; discussion 1468-70. PubMed ID: 2585556
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.
    Parravicini L; Arpini A; Bamonte F; Marzanatti M; Ongini E
    Toxicol Appl Pharmacol; 1982 Sep; 65(2):222-30. PubMed ID: 7179282
    [No Abstract]   [Full Text] [Related]  

  • 78. [Gentamicin and amikacin nephrotoxicity: comparative study in patients with initially normal renal function].
    Ballesteros J; Northland R; Wolff M
    Rev Med Chil; 1989 Jan; 117(1):10-7. PubMed ID: 2641618
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients.
    Schentag JJ; Cerra FB; Plaut ME
    Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.